2024-08-28-港交所-ＦＬ二富邦台湾_ＦＩ富邦台湾_未经审核中期报告_-_2024年6月30日_只备有英文版_24页_282kb

Fubon Leveraged & Inverse Series 2024 Interim Report Summary

Key Financial Highlights:

• Net Assets:
  As of 30 June 2024:

  • Fubon FTSE Taiwan Daily (2x) Leveraged Product: USD 1,829,206 (from USD 1,960,229 in Dec 2023).
  • Fubon FTSE Taiwan Daily (-1x) Inverse Product: USD 499,270 (versus USD 409,121 in Dec 2023).

• Performance:
  During Jan–Jun 2024:

  • 2x Leveraged Product: Net asset value increased 48.9% (aligned with twice the FTSE Taiwan RIC Capped Index growth of ~24.6%).
  • -1x Inverse Product: Net asset value decreased 20.9% (offsetting the index’s rise).

• Financial Operations:

  • Gross income driven by gains on financial assets/liabilities and foreign exchange.
  • Expenses include management and trustee fees. Downloads in Dec 2023 saw higher operating liabilities and net asset reductions for the inverse product.

Investment Portfolio:

• Both sub-funds primarily use futures contracts for exposure to the FTSE Taiwan RIC Capped Index:
  • Leveraged Product (2x): Held two long-term futures contracts with fair values totalling USD 14,130 (~0.77% of net assets).
  • Inverse Product (-1x): Utilized short-term futures contracts with a fair value of USD (-1,940) (~-0.39% of net assets).
• All investments classified under HKFRS for fair value measurement.

Governance and Structure:

• Management: Fubon Fund Management (Hong Kong), overseen by the Hong Kong Securities and Futures Commission.
• Accounting Policies: Compliant with HKFRS; foreign currency transactions in USD; fair value based on market quotes.

Notes:

• Leverage products carry amplified risk due to daily resetting and market volatility.
• Redemption volumes rose (particularly for the leveraged fund) impacting unit issuance.

(Please note the summary is concise based on provided financial report; full details reference the report tables and disclosures.)